Six Buschke-Lowenstein tumors, i.e., highly differentiated squamous cell tumors of the genital region, were shown to contain human papillomavirus 6 (HPV 6) or HPV It is well established that benign genital warts (condylomata) are caused by human papillomaviruses (HPV): HPV type 6 (HPV 6) or HPV 11 can be detected in over 90% of these lesions (9, 12) , and very recently, it has been shown that in vitro infection of human cervical tissue explants with these HPV types elicited a histological picture typical for genital warts (14) . Buschke-Lowenstein tumors or giant condylomata are large verrucous genital tumors which do not metastasize (2) , but clinically they are nevertheless regarded as malignant (8) . Histologically, they share many features with condylomata acuminata, but ultrastructurally, they show some Bowenoid features (13) . It has been suggested that the Buschke-Lowenstein tumor might be an intermediate lesion within a continuous spectrum of biologically related tumors ranging from the condyloma to the invasive squamous cell carcinoma (4, 17) . Malignant genital tumors and preneoplastic lesions are strongly associated with HPV 16 and HPV 18, whereas HPV 6 and HPV 11 seem to be mostly confined to benign condylomatous lesions (1, 6, 11) . Exceptions seem to exist, however, as HPV 6 or HPV 11 DNA has been detected in a few Buschke-Lowenstein tumors analyzed earlier (9, 15) (12) and differential reactivity * Corresponding author.
with the HPV 6 and HPV 11 probes (not shown) allowed precise typing (Fig. 1) . No additional signals were detected when hybridizing under low-stringency conditions (Tm, -40°C) with HPV 6 DNA ( Fig. 1) (Fig. 2) . The typical pattern of forms I, II, and III of free episomal HPV genomes was visible in all tumor DNAs after digestion with different noncut enzymes. Very faint additional bands could be detected in the highmolecular-weight region of the gel. They were, however, identified as circular oligomers, as their size was identical in all tumors; they disappeared completely after digestion with a one-cut enzyme, and they could not be mobilized by different noncut enzymes that are known to cleave frequently within the human genome (Fig. 2) (Fig. 3). (5) and sequenced (18) . The genomes of the three cloned HPV 6 subtypes were linearized by BamHI cleavage, gel purified from the vector sequences, and subjected to restriction analysis with 13 different endonucleases, thus probing for differences at 27 cleavage sites predicted by the HPV 6b sequence. HPV 6b and HPV 6d differed at only 1 of the 27 sites, HPV 6a and HPV 6d differed at 3 sites, and HPV 6a and HPV 6b differed at 4 sites, thus reflecting a very high similarity of the HPV 6 subtypes (data not shown). The size difference of HPV 6d relative to HPV 6a ( Fig. 1) As a result, no differences could be detected between restriction fragments from the late side of the noncoding regions of the HPV 6a, HPV 6b, and HPV 6d genomes in tumors and condylomata and the corresponding fragments of the cloned HPV 6a and HPV 6d DNA (data not shown). The HPV 6b clone pAmp2 used for sequence analysis of that region by Schwarz et al. (18) was, however, shown to bear a deletion of about 120 bp (Fig. 3 ). This part of the genome is very rich in alternating purine-thymidine nucleotides and thus, cloning in Escherichia coli may result in deletions by recA-independent recombination of short direct sequence repetitions, according to a model proposed by Collins et al. (3) .
The presence of HPV 6 or HPV 11 and the episomal state of the viral genomes clearly distinguish Buschke-Lowenstein tumors from invasive genital carcinomas, which mostly harbor integrated copies of HPV 16 or HPV 18 DNA (1, 6, 7). The tandem duplication of 459 bp within the noncoding region of HPV 6d is of considerable interest as it duplicates the putative control elements and start sites for early gene transcription. Enhanced or deregulated early gene expression might be the consequence and could confer a higher tumorigenic potential to a virus which usually induces benign tumors (condylomata). A similar mechanism has been evidenced for human papovavirus BK: in a number of BK virus mutants which transform rodent cells much more efficiently than wild type BK, sequence rearrangements affecting the viral enhancer (68-bp repeat) within the noncoding region of the genome have been found (19) . These rearrangements are responsible for the phenotype of the mutants (19, 21) , and, as far as was analyzed, deregulated, continuous expression of early gene functions of the mutant genomes was observed (20 4, 8, 12, 16, 20) , separated in a 0.5% agarose gel, transferred to a nitrocellulose filter, and hybridized under stringent conditions with nick-translated 32P-labeled HPV 6d DNA. Lanes 1 through 4 HPV lic DNA; lanes 5 through 8, HPV lla DNA; lanes 9 through 12, HPV 6d DNA; lanes 13 through 16 HPV 6a DNA; lanes 17 through 20, HPV 6a DNA. The positions of nicked circles (form II), linear molecules (form III), and covalently closed circles (form I) are indicated by arrows. The amount of form I was low after digestion with BclI, due to a nicking activity in this enzyme preparation. X HindIII fragments were used as markers. of cervical cancer (22 
